Product complaint # (b)(4).Investigation summary.No device associated with this report was received for examination.A worldwide lot specific complaint database search, or device history record (dhr) review was not possible because the required lot code(s) was not provided.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Corrective action was not indicated.(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.(b)(4).
|
"literature article entitled, ¿revisions of metal-on-metal hip resurfacing: lessons learned and improved outcome¿ by koen a.Se smet, md, published by orthopedic clinics north america (2011), no.42, pp.259-269, was reviewed.The aim of this retrospective, consecutive case series of a single surgeon was to assess the outcome following revision of mom hemiarthroplasties.In addition, the authors assessed whether the lessons learned from the initial previously reported experience improved outcome, and whether screening with the use of metal ions had an effect on post-revision outcome.This complaint captures the revised depuy mom components.The products used at revision are unknown.Implanted products: 10 asr hemiarthroplasties (cup and head) and 2 asr xl thas (cup, head, augment).The remainder of the 113 hips studied were from competitor products.Results: the results of this study were not separated by product and/or manufacturer.This complaint will capture all reported reasons for revision surgery and intraoperative findings.57 cup malpositioning.15 cup loosening.11 head misposition.21 head loosening.57 osteolysis (acetabular and femoral).6 periprosthetic femur fractures.6 infections.40 elevated blood heavy metal.Mean co 22.42 ppb and mean cr 22.39 ppb.Intraoperative findings: osteolysis, unspecified impingement, oversized components (unspecified components and locations), metallosis, metal debris, hypersensitivity (pseudotumor), and soft tissue fluid collections, and ground swelling.There were six instances of femoral component loosening attributed to pseudotumor formation.The authors found significant wear on the bearing surfaces intraoperatively.Only 4 patients requiring surgery reported no pain.This complaint captures all adverse events and intraoperative findings listed within the article.The authors do not specify which product or manufacturer is associated with each event.Included within this complaint: 1 asr hemiarthroplasty (head and cup) and 1 ars-xl (head, cup, augment).The implants used in the revision surgery were competitor products and are therefore not captured within this complaint.The authors provide radiographic evidence and patient identifiers for one patient having an asr hemiarthroplasty revised.This information is captured on the attached guidance document and should be linked to parent (b)(4)." case 1, (b)(6) yo female.Perioperative radiographs available on pp.265 of the article.(b)(6) yo female patient with asr hip resurfacing.Preoperative dx: osteoarthritis.Revised cup and femoral component at 27 months.Intraoperative findings: cup malpositioning with excessive inclination and anteversion, elevated blood metal ions: cr 56.9 ppb and co 72.4 ppb, and femoral head osteolysis.Histological findings: pseudotumor invasion of the resurfaced femoral head with invasive metal-filled macrophages absorbing the viable bone.
|